Lipidor AB is a Swedish drug delivery company focusing on topical medication. The company was established in 2009 in order to develop, patent and commercialize formulation concepts and technologies based on lipids.
The founders’ expertise, gained from working with lipids for more than 30 years, together with pharmaceutical development experience, has led to the conviction that major opportunities exist for advanced lipid-based drug delivery systems that offer benefits over current approaches.
The company’s proprietary AKVANO® technology represents a completely new topical dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. An initial sprayable product concept for treating plaque psoriasis is currently in clinical development.
Research and development is conducted at Karolinska Institutet and Stockholm University. Lipidor is owned by its founders, Karolinska Development AB, Cerbios-Pharma SA, Aurena Laboratories and private investors (3).